Mixed hyperlipidemia

Clinical trials for Mixed hyperlipidemia explained in plain language.

Never miss a new study

Get alerted when new Mixed hyperlipidemia trials appear

Sign up with your email to follow new studies for Mixed hyperlipidemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New cholesterol drug QLC7401 enters final testing phase

Disease control Not yet recruiting

This Phase 3 trial tests a new drug called QLC7401 in about 780 adults with high cholesterol that remains high despite standard therapy. Participants will receive either QLC7401 or a placebo, added to their current cholesterol medications. The main goal is to see if QLC7401 can s…

Matched conditions: MIXED HYPERLIPIDEMIA

Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

Mixed hyperlipidemia

Get alerted when new Mixed hyperlipidemia trials appear

New cholesterol drug QLC7401 enters final testing phase